USD573M in retained losses and a less than great 2020!. 2021 a year that cannot get worse, page-8

  1. 1,727 Posts.
    lightbulb Created with Sketch. 141
    Funnily enough they said the same about covid ards last year.

    We are targeting the sickest of the sick where our cells are proven (In phase 2 trials) to be most effective. Fast forward to phase 3 trial results, we didn't reach our primary endpoint goals as our cells were given too late. They need to be given as early as possible to be most effective.

    I'm expecting by end of 2021 for the team to say our cells as most effective when dosed 365 days a year.
    Last edited by Halime: 05/01/21
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.63
Change
0.015(0.93%)
Mkt cap ! $2.082B
Open High Low Value Volume
$1.63 $1.67 $1.61 $6.975M 4.265M

Buyers (Bids)

No. Vol. Price($)
1 707 $1.63
 

Sellers (Offers)

Price($) Vol. No.
$1.64 7320 2
View Market Depth
Last trade - 16.10pm 04/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.